Focusing on 2026 as a starting point, PwC has laid out several “strategic imperatives” pharma companies ought to pursue this ...

A worldwide leader in injectable drug administration will be the newest company to set up shop in Greenfield, and anticipates ...

As they prepare for the J.P. Morgan Healthcare Conference next week, biotech leaders and analysts say companies are better ...

Enter generative AI, which the pharma industry is adopting at a terrific rate. By ingesting and analysing vast biological ...

Biotech Showcase™ Provides Private and Micro- to Mid-Cap Public Company Executives One-Stop Access to Investors, Pharma ...

F rom blockbuster drugs that garner media attention to smaller innovations that help millions maintain health, the biotech and pharmaceutical industries have an impact on everyone’s life. Meanwhile, ...

Fierce Biotech sat down with Pavel Raifeld, CEO of Innoviva, to explore the dynamic landscape of the biotech industry. Throughout the conversation, Raifeld offers a unique perspective on the most ...

Our first biotech bi-weekly of 2026 is here with recent innovations in genomic drug discovery, organoid development and ADC ...

"The conditions are perfect" for biotech's big annual party in San Francisco, an industry leader told the Business Times.

Forecasters anticipate exponential growth throughout the biotech industry over the coming decade, paving the way for a series of stock market opportunities for investors throughout this period. The ...

Sun Pharma's Managing Director, Kirti Ganorkar, predicts that new age medicines for obesity and diabetes will drive the ...

A life-sciences job in Boston used to be a sure path to a high-paying career, but empty labs and unemployed grads now herald ...